NeuralBase AI Ltd., operating under its enterprise brand BMP AI, has acquired HeartEase, an AI-powered diagnostic platform that uses smartphone microphones to detect early signs of heart abnormalities. This acquisition represents a strategic move to integrate wellness-focused, preventive healthcare solutions into NeuralBase's enterprise AI chatbot ecosystem. The technology addresses a growing corporate demand for integrated employee wellness solutions that extend beyond traditional mental health support, offering a non-invasive, accessible, and real-time method for heart health screening.
The HeartEase platform requires no external hardware beyond a smartphone, positioning it to revolutionize how enterprises care for their workforce by embedding preventive health screening into employees' daily digital experiences. Vighnesh Dobale, CEO of NeuralBase, emphasized the transformative potential of the acquisition, stating that HeartEase will become a revolutionary platform due to its use of artificial intelligence and mobile technology for early detection of heart abnormalities. Key features of the platform include smartphone-only diagnostics, global accessibility, privacy-focused updates, and a scalable roadmap for future health screenings.
This strategic acquisition not only enhances BMP AI's chatbot platform but also redefines technology's role in protecting and empowering individuals in their everyday lives. With HeartEase's backend AI engine already trained using validated clinical datasets, a Minimum Viable Product is expected for field testing in Q4 2025, targeting enterprise clients, wellness programs, and rural health campaigns. The move underscores the increasing recognition of the return on investment from employee wellness initiatives, which can lead to reduced healthcare costs, improved productivity, and better retention rates.
NeuralBase's commitment to building technologies that scale ethically, inclusively, and intelligently is evident in this acquisition, positioning the company at the forefront of AI-driven preventive healthcare. The integration of HeartEase into NeuralBase's ecosystem represents a significant advancement in making preventive health screening more accessible and integrated into daily life, particularly within corporate environments where employee wellness has become a strategic priority. For regulatory information about the company, investors can visit https://www.sec.gov.
